Company Overview

Update
Status:
Acquired by Bayer HealthCare
Founded:
2000
Headquarters:
Cologne
Funding:
$33.2M
Categories:
Biotechnology
Description:
DIREVO Industrial Biotechnology is focused on the biomass conversion industry and provides customized solutions for various industries.

Detailed Description

Update

DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.

Current Team (2)

Update

Past Team (1)

Update

Funding Rounds (3) - $33.2M

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    Nattermannallee 1

    Cologne, D - 50829

    DEU

Images (1)

Update
  • 2895ee1ceedb214cff538848f01e934e